293 related articles for article (PubMed ID: 21315279)
1. Synthesis of hypoxia imaging agent 1-(5-deoxy-5-fluoro-α-D-arabinofuranosyl)-2-nitroimidazole using microfluidic technology.
Bouvet VR; Wuest M; Wiebe LI; Wuest F
Nucl Med Biol; 2011 Feb; 38(2):235-45. PubMed ID: 21315279
[TBL] [Abstract][Full Text] [Related]
2. [
Schweifer A; Maier F; Ehrlichmann W; Lamparter D; Kneilling M; Pichler BJ; Hammerschmidt F; Reischl G
Nucl Med Biol; 2016 Dec; 43(12):759-769. PubMed ID: 27693670
[TBL] [Abstract][Full Text] [Related]
3. β -[
Kumar P; Roselt P; Reischl G; Cullinane C; Beiki D; Ehrlichmann W; Binns D; Naimi E; Yang J; Hicks R; Machulla HJ; Wiebe LI
Curr Radiopharm; 2017; 10(2):93-101. PubMed ID: 28294075
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of [
Sun W; Falzon C; Naimi E; Akbari A; Wiebe LI; Tandon M; Kumar P
Curr Radiopharm; 2019; 12(1):49-57. PubMed ID: 30338747
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic technology: an economical and versatile approach for the synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET).
Bouvet V; Wuest M; Tam PH; Wang M; Wuest F
Bioorg Med Chem Lett; 2012 Mar; 22(6):2291-5. PubMed ID: 22342141
[TBL] [Abstract][Full Text] [Related]
6. Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation.
Reischl G; Ehrlichmann W; Bieg C; Solbach C; Kumar P; Wiebe LI; Machulla HJ
Appl Radiat Isot; 2005 Jun; 62(6):897-901. PubMed ID: 15799867
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, radiofluorination, and hypoxia-selective studies of FRAZ: A configurational and positional analogue of the clinical hypoxia marker, [18F]-FAZA.
Kumar P; Naimi E; McEwan AJ; Wiebe LI
Bioorg Med Chem; 2010 Mar; 18(6):2255-2264. PubMed ID: 20181485
[TBL] [Abstract][Full Text] [Related]
8. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of [(18)F]FMISO in a flow-through microfluidic reactor: Development and clinical application.
Zheng MQ; Collier L; Bois F; Kelada OJ; Hammond K; Ropchan J; Akula MR; Carlson DJ; Kabalka GW; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):578-84. PubMed ID: 25779036
[TBL] [Abstract][Full Text] [Related]
10. A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
Furukawa T; Yuan Q; Jin ZH; Aung W; Yoshii Y; Hasegawa S; Endo H; Inoue M; Zhang MR; Fujibayashi Y; Saga T
Oncol Rep; 2015 Sep; 34(3):1379-87. PubMed ID: 26134305
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three
Dos Santos SN; Wuest M; Jans HS; Woodfield J; Nario AP; Krys D; Dufour J; Glubrecht D; Bergman C; Bernardes ES; Wuest F
Nucl Med Biol; 2023; 124-125():108383. PubMed ID: 37651917
[TBL] [Abstract][Full Text] [Related]
12. Microwave-assisted radiosynthesis of the hypoxia marker 1-α-D-(5- deoxy-5-[18F]fluoroarabinofuranosyl)-2-nitroimidazole ([18F]FAZA).
Kumar P; Ortlieb R; Gupta AK; Wiebe LI
Curr Radiopharm; 2014; 7(1):49-56. PubMed ID: 25022345
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preclinical characterization of 1-(6'-deoxy-6'-[
Wanek T; Kreis K; Križková P; Schweifer A; Denk C; Stanek J; Mairinger S; Filip T; Sauberer M; Edelhofer P; Traxl A; Muchitsch VE; Mereiter K; Hammerschmidt F; Cass CE; Damaraju VL; Langer O; Kuntner C
Bioorg Med Chem; 2016 Nov; 24(21):5326-5339. PubMed ID: 27614920
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic radiosynthesis and biodistribution of [18 F] 2-(5-fluoro-pentyl)-2-methyl malonic acid.
Dewkar GK; Sundaresan G; Lamichhane N; Hirsch J; Thadigiri C; Collier T; Hartman MC; Vaidyanthan G; Zweit J
J Labelled Comp Radiopharm; 2013 May; 56(5):289-94. PubMed ID: 24285373
[TBL] [Abstract][Full Text] [Related]
15. Efficient radiosynthesis of 3'-deoxy-3'-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip.
Javed MR; Chen S; Kim HK; Wei L; Czernin J; Kim CJ; van Dam RM; Keng PY
J Nucl Med; 2014 Feb; 55(2):321-8. PubMed ID: 24365651
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 2-amino-5-(4-[(18)F]fluorophenyl)pent-4-ynoic acid ([(18)F]FPhPA): a novel (18)F-labeled amino acid for oncologic PET imaging.
Way JD; Wang M; Hamann I; Wuest M; Wuest F
Nucl Med Biol; 2014 Sep; 41(8):660-9. PubMed ID: 24993371
[TBL] [Abstract][Full Text] [Related]
17. Automated radiosynthesis of GMP quality [18F]HX4 for PET imaging of hypoxia.
Turton DR; Betts HM; Dutton D; Perkins AC
Nucl Med Biol; 2015 May; 42(5):494-498. PubMed ID: 25725983
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
[TBL] [Abstract][Full Text] [Related]
19. Simple, column purification technique for the fully automated radiosynthesis of [18F]fluoroazomycinarabinoside ([18F]FAZA).
Nandy SK; Rajan MG
Appl Radiat Isot; 2010 Oct; 68(10):1944-9. PubMed ID: 20478712
[TBL] [Abstract][Full Text] [Related]
20. Impact of structural alterations on the radiopharmacological profile of
Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
